BioSpace News Archive

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), today announced that Keros’ President and Chief Executive Officer Jasbir S. Seehra, Ph.D. will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, is pleased to announce the company’s participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference.

Scopus BioPharma Inc. today announced it has entered into securities purchase agreements with certain institutional investors in connection with a private placement priced at-the-market under Nasdaq rules of 3,000,000 shares of common stock,

Oryzon Genomics, S.A., a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced that Dr. Saikat Nandi has been appointed as Global Chief Business Officer.

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will host an inaugural Spatial Day on December 15, 2021 at 12 p.m. ET.

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that it has been named a Top Workplace by The San Diego Union-Tribune for the fifth consecutive year.

Advaxis, Inc. announced that it has received a letter from the Nasdaq Hearings Panel providing Advaxis an extension through December 20, 2021, to complete its business combination with Biosight, Ltd. and demonstrate compliance with all applicable requirements for initial listing on The Nasdaq Capital Market.

Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, announced the results of U.S. hospital claims data analysis showing hospital inpatient mortality and length of hospital stay for cardiogenic shock patients.

Carrick Therapeutics today announces two presentations at the 2021 San Antonio Breast Cancer Symposium (SABCS), to be held from December 7-10, 2021.

At the opening ceremony of the 4th China International Import Expo (CIIE) held in Shanghai on November 6, 2021, SYZJ001, a bispecific antibody drug against COVID-19 jointly developed by Shanghai ZJ Bio-Tech Co., Ltd. and Sanyou Biopharmaceuticals (Shanghai) Co., Ltd., made a brilliant appearance.